IRIS
MIMMI, SELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 951
EU - Europa 598
AS - Asia 477
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
Totale 2.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 912
IT - Italia 394
SG - Singapore 316
CN - Cina 96
SE - Svezia 54
DE - Germania 40
CA - Canada 38
GB - Regno Unito 30
IN - India 20
FR - Francia 14
KR - Corea 14
FI - Finlandia 12
HK - Hong Kong 11
RO - Romania 9
CZ - Repubblica Ceca 8
BR - Brasile 7
PL - Polonia 7
JP - Giappone 5
NL - Olanda 5
PT - Portogallo 5
RU - Federazione Russa 4
UA - Ucraina 4
GR - Grecia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
EE - Estonia 2
ES - Italia 2
EU - Europa 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
NZ - Nuova Zelanda 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
IQ - Iraq 1
LK - Sri Lanka 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 2.042
Salva come PNG Salva come JPEG
Città #
Chandler 167
Singapore 133
Catanzaro 79
Santa Clara 74
Milan 66
Lawrence 60
Princeton 60
Ottawa 31
Wilmington 30
Seattle 28
Ashburn 26
Boardman 24
London 24
Des Moines 20
Chicago 16
Rome 16
Munich 15
Napoli 14
Helsinki 11
Shanghai 11
Beijing 9
Hong Kong 9
Redmond 9
Augusta 8
Olomouc 8
Redwood City 8
Foggia 7
Los Angeles 7
Seoul 7
Guangzhou 6
Marano 6
Modena 6
Norwalk 6
Paris 6
Hanover 5
Pune 5
Teresina 5
Chennai 4
Edmonton 4
Heidesheim 4
Latina 4
Naples 4
Padova 4
Providence 4
Reggio Calabria 4
Shenzhen 4
Taranto 4
Târgu Mureş 4
Xi'an 4
Crosia 3
Derby 3
Felgueiras 3
Ferrara 3
Florence 3
Huddinge 3
Lamezia Terme 3
San Francisco 3
San Jose 3
Villanova d'Asti 3
Washington 3
Wuhan 3
Adrano 2
Auckland 2
Aversa 2
Bagnara Calabra 2
Belgrade 2
Bonn 2
Brooklyn 2
Caserta 2
Clearwater 2
Clifton 2
Cosenza 2
Dalian 2
Dalmine 2
Dubai 2
Genoa 2
Hangzhou 2
Istanbul 2
Jiaxing 2
Jülich 2
King of Prussia 2
Livorno 2
Lowell 2
Ludhiana 2
Mapo-gu 2
Milazzo 2
Montalto Uffugo 2
Mugnano di Napoli 2
Nanchang 2
Omaha 2
Palembang 2
Romainville 2
Saint-Fons 2
San Nicola Manfredi 2
Songpa-gu 2
Suseong-gu 2
São Paulo 2
Timisoara 2
Torre Del Lago 2
Vibo Valentia 2
Totale 1.184
Salva come PNG Salva come JPEG
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 99
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 67
PEPTIDI E LORO USI 66
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 62
A Candidate multi-targeting approach to block the CD98hc oncoprotein 58
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 54
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 45
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 44
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 44
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 43
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 41
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 40
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 40
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 39
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 39
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 38
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 37
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 36
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 36
A novel phage display based platform for exosome diversity characterization 36
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 35
PEPTIDE AND USES THEREO 35
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 35
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 33
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 32
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 31
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 31
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 30
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 30
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 30
Crucial role for IBtk in the survival and maintenance of mature B cells 30
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 30
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 30
Phage Display: An Overview in Context to Drug Discovery 29
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 29
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 28
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 28
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 28
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 27
Phage Display: An Overview in Context to Drug Discovery 26
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 26
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 26
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 26
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 26
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 25
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 25
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 24
Insights into Thymus Development and Viral Thymic Infections 24
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 24
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 24
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 24
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 23
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 22
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 20
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 19
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 17
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 16
Peptide-guided targeting of GPR55 for anti-cancer therapy 15
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 15
Belantamab mafodotin in multiple myeloma 14
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 14
Peptide-guided targeting of GPR55 for anti-cancer therapy. 13
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 12
Isatuximab in multiple myeloma 11
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 11
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 11
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 10
null 10
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 10
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 9
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 8
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 8
null 6
null 2
Totale 2.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 0 0 0 0 0 0 0 0 9 36
2020/2021176 11 7 6 5 5 26 16 2 33 37 18 10
2021/2022268 6 2 13 56 20 12 15 60 19 34 29 2
2022/2023559 122 26 38 23 52 37 7 53 108 38 41 14
2023/2024312 59 38 31 23 21 65 6 10 6 6 17 30
2024/2025679 130 39 46 38 98 104 27 26 145 25 1 0
Totale 2.141